Formulations containing a somatostatin receptor agonist
US11564968B2 · kind B2 · utility
0Cited by
4References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2021 |
| Grant date | Jan 31, 2023 |
| Priority date | — |
| Expiry date | Oct 1, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pre-formulations comprising: The invention further relates to methods of treatment comprising administration of such pre-formulations, to pre-filled administration devices and kits containing the formulations, to the use of an alkylammonium EDTA salt to reduce the decomposition of the lipid components and/or any active agent contained within the pre-formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.